A team of researchers published the results of a phase 1 clinical trial for the drug Givosiran, which targets the liver cells ultimately responsible for acute hepatic porphyrias.
The annual #RUN2U event featured a patient panel sharing their experiences of living with rare and undiagnosed diseases with future health care providers.
New research is showing that bacteriophages have the potential to shape the communities that live within the gut and ultimately your health—for better or worse.
On this International Women’s Day, U of U Health cardiologist Rashmee Shah, MD, explains why gender balance isn’t a women’s issue, it is something everyone should be thinking about.
To help promote the highest standards of care, and improve the overall rates of survival and recovery following TBI, experts issued the 3rd edition of the Brain Trauma Foundation Guidelines...
The human immune system is notorious for overreacting to common infections. University of Utah Health researchers have shown how one component of the immune system might have evolved to limit...
University of Utah Health is proud to present One in a Million, an original short documentary co-directed by two acclaimed independent filmmakers, Jeremiah Zagar and Ross Kauffman.
An International consortium of researchers mines large datasets to identify a common genetic architecture for Polycystic Ovary Syndrome improving our understanding of a leading cause of female infertility.
Highlighting investigators and their pioneering research programs, the Vitae program seeds new collaborations and development strategies by humanizing research through story.
The Immunology, Inflammation and Infectious Disease Initiative (3i) at the University of Utah Health has awarded seed grants to eight collaborative research projects.
The Immunology, Inflammation and Infectious Disease Initiative (3i) at the University of Utah Health has awarded seed grants to eight collaborative research projects.
